<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04671342</url>
  </required_header>
  <id_info>
    <org_study_id>SRC_SLE_Sparkle_PSG_2020_10908</org_study_id>
    <nct_id>NCT04671342</nct_id>
  </id_info>
  <brief_title>DreamKit Diagnostic Validation</brief_title>
  <official_title>Diagnostic Validation of the DreamKit Device Against Polysomnography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Philips Clinical &amp; Medical Affairs Global</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Philips Clinical &amp; Medical Affairs Global</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study has been developed in order to demonstrate diagnostic efficacy of the DreamKit&#xD;
      device against polysomnography.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this study is to assess the diagnostic performance of the DreamKit&#xD;
      device against the gold-standard comparator, polysomnography (PSG). Data collection will be&#xD;
      completed within a single visit, in which participants will undergo simultaneous measurement&#xD;
      using the DreamKit device and in-laboratory PSG.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 14, 2021</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Apnea hypopnea index</measure>
    <time_frame>Baseline</time_frame>
    <description>The primary endpoint is the intraclass correlation coefficient (ICC) for absolute agreement between the polysomnography (PSG) apnea-hypopnea index (AHI) and the DreamKit-AHI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Central apnea index</measure>
    <time_frame>Baseline</time_frame>
    <description>The secondary endpoint is the ICC for absolute agreement between the PSG-central apnea index (CAI) and the DreamKit-CAI.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Sleep Apnea, Obstructive</condition>
  <condition>Sleep Apnea, Central</condition>
  <arm_group>
    <arm_group_label>Validation Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will wear the DreamKit device (test device) while instrumented with polysomnography sensors (gold standard).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DreamKit</intervention_name>
    <description>The DreamKit device is a single-use device intended to aid the diagnosis of sleep-disordered breathing.</description>
    <arm_group_label>Validation Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged â‰¥18 years;&#xD;
&#xD;
          -  Fluent in English;&#xD;
&#xD;
          -  Able to provide informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Self-reported habitual sleep duration of &lt;4 hours/night on average (&quot;How many hours&#xD;
             sleep do you usually get per night?&quot;);&#xD;
&#xD;
          -  Circadian phase disorder, shift work, or any other issue/condition that would, in the&#xD;
             opinion of the site investigator, reduce the likelihood of obtaining at least four&#xD;
             hours of sleep during the overnight study;&#xD;
&#xD;
          -  History of allergic reactions to medical adhesives;&#xD;
&#xD;
          -  Skin rash or other dermatological condition that would impact correct placement of the&#xD;
             DreamKit device and/or PSG sensors, and/or would be exacerbated by the presence of the&#xD;
             device or sensors;&#xD;
&#xD;
          -  Presence of a pacemaker;&#xD;
&#xD;
          -  Severe medical condition (controlled or uncontrolled) that would impede data&#xD;
             collection in the opinion of the site investigator, including the requirement for&#xD;
             oxygen therapy;&#xD;
&#xD;
          -  [for those currently using overnight therapy]: Unwilling to withdraw from overnight&#xD;
             therapy for a single night and/or clinically unsuitable to withdraw from overnight&#xD;
             therapy in the opinion of the site investigator, with overnight therapy including but&#xD;
             not limited to any form of PAP or ventilation, oral device including mandibular&#xD;
             advancement devices or mouthguard for bruxism, nasal dilator strips, and/or positional&#xD;
             device;&#xD;
&#xD;
          -  [for those currently using overnight therapy]: Considered by the site investigator to&#xD;
             be at risk of an AE resulting from hypersomnolence the day after the overnight visit,&#xD;
             such as a high-risk occupation including but not limited to a pilot or commercial&#xD;
             driver;&#xD;
&#xD;
          -  An employee, or family member of an employee, of a company that designs, sells, or&#xD;
             manufactures sleep related products (including Philips).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bill Hardy</last_name>
    <role>Study Director</role>
    <affiliation>Philips Sleep &amp; Respiratory Care</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bill Hardy</last_name>
    <phone>412-874-2710</phone>
    <email>bill.hardy@philips.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sleep Disorders Center of Alabama</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Delta Waves, Inc.</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80918</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joe Schulz</last_name>
      <phone>719-262-9283</phone>
      <email>joe@deltawaves.org</email>
    </contact>
    <investigator>
      <last_name>Samuel Scheuller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Lung and Sleep Associates</name>
      <address>
        <city>Lehigh Acres</city>
        <state>Florida</state>
        <zip>33971</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed El-Gendy</last_name>
      <phone>239-369-3333</phone>
      <email>ahmed@floridalung.com</email>
    </contact>
    <investigator>
      <last_name>Alaa El-Gendy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pulmonary and Critical Care Association of Baltimore</name>
      <address>
        <city>Towson</city>
        <state>Maryland</state>
        <zip>21286</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stuart King</last_name>
      <phone>443-841-9562</phone>
      <email>sking@pccabpa.com</email>
    </contact>
    <investigator>
      <last_name>Alan Schwartz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clayton Sleep Institute</name>
      <address>
        <city>Maplewood</city>
        <state>Missouri</state>
        <zip>63143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Uhles</last_name>
      <phone>314-645-5855</phone>
      <email>uhlesm@claytonsleep.com</email>
    </contact>
    <investigator>
      <last_name>Joseph Ojile, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Berks Schuylkill Respiratory Specialists</name>
      <address>
        <city>Wyomissing</city>
        <state>Pennsylvania</state>
        <zip>19610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Hill</last_name>
      <phone>610-685-5864</phone>
      <email>lhill@lungmd.net</email>
    </contact>
    <investigator>
      <last_name>Daron Kahn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bogan Sleep Consultants</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>December 9, 2020</study_first_submitted>
  <study_first_submitted_qc>December 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2020</study_first_posted>
  <last_update_submitted>October 25, 2021</last_update_submitted>
  <last_update_submitted_qc>October 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Sleep Apnea, Central</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

